Skip to main content

Table 4 Target groups for prophylaxis with publicly purchased antivirals (n = 25).

From: Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California

 

Size of Population Served

  
 

Small (< 50,000)

Medium (50,000-499,999)

Large (500,000+)

All LHDs

Eligible Group

n

(%)

n

(%)

n

(%)

n

(%)

Household members of persons with H1N1 influenza

3

(100)

10

(77)

4

(44)

17

(68)

Persons at high-risk for medical complications of influenza (e.g. pregnant women)

3

(100)

4

(31)

5

(56)

12

(48)

Healthcare workers

2

(67)

4

(31)

3

(33)

9

(36)

Other first responders

2

(67)

1

(8)

1

(11)

4

(16)

Household members of healthcare workers

1

(33)

0

(0)

1

(11)

2

(8)

Other

0

(0)

3

(23)

3

(33)

6

(24)

Don't know/Unable to answer

0

(0)

2

(15)

2

(22)

4

(16)

Total

3

 

13

 

9

 

25

 
  1. Among the twenty-five local health departments (LHDs) reporting that publicly purchased antivirals could be used for pre- or post-prophylaxis, Table 4 summarizes the groups eligible for prophylaxis with publicly purchased antivirals, stratified by size of population served by LHD
  2. **Indicates statistically significant difference with respect to population size served by LHD (Fisher's exact test, p < .05)